By: Sara Riascos  May. 16, 2022

Dexur’s analysis of Real World Evidence based on Medicare Claims data showed that the use of Bumetanide within 7 days of hospitalization was associated with lower hospital readmission rates for Heart Failure Patients at AdventHealth Orlando in Orlando, Florida. Reduction in readmission rates helps hospitals improve their outcomes for various cost and quality programs. Dexur is an approved entity to perform Medicare claims data analysis, which it uses to perform quality outcomes analysis. Dexur has published several papers with Harvard Medical School on quality outcomes related topics. Dexur’s analysis of drugs and their impact on quality outcomes, such as readmissions and mortality, are used by Hospitals, IDNs, and ACOs to implement best practices and manage Real World Evidence based risk factors.

By: Sara Riascos  Mar. 10, 2022

Heart Failure is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Torsemide is a diuretic used to treat fluid overload due to heart failure, kidney disease, liver disease and high blood pressure. Studies have shown that patients treated with torasemide for up to 1 year decreased Heart Failure severity. Other studies have shown that torsemide may be superior compared to other drugs when it comes to reducing Heart Failure hospitalizations.

By: Sara Riascos  Mar. 09, 2022

Heart Failure is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Torsemide is a diuretic used to treat fluid overload due to heart failure, kidney disease, liver disease and high blood pressure. Studies have shown that patients treated with torasemide for up to 1 year decreased Heart Failure severity. Other studies have shown that torsemide may be superior compared to other drugs when it comes to reducing Heart Failure hospitalizations.

By: Sara Riascos  Mar. 08, 2022

Background:

Heart Failure is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Torsemide is a diuretic used to treat fluid overload due to heart failure, kidney disease, liver disease and high blood pressure. Studies have shown that patients treated with torasemide for up to 1 year decreased Heart Failure severity. Other studies have shown that torsemide may be superior compared to other drugs when it comes to reducing Heart Failure hospitalizations.

By: Sara Riascos  Mar. 07, 2022

Heart Failure is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Torsemide is a diuretic used to treat fluid overload due to heart failure, kidney disease, liver disease and high blood pressure. Studies have shown that patients treated with torsemide for up to 1 year decreased Heart Failure severity. Other studies have shown that torsemide may be superior compared to other drugs when it comes to reducing Heart Failure hospitalizations.

By: Sara Riascos  Mar. 04, 2022

Heart Failure is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Torsemide is a diuretic used to treat fluid overload due to heart failure, kidney disease, liver disease and high blood pressure. Studies have shown that patients treated with torasemide for up to 1 year decreased Heart Failure severity. Other studies have shown that torsemide may be superior compared to other drugs when it comes to reducing Heart Failure hospitalizations.

By: Sara Riascos  Mar. 03, 2022

Heart Failure is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Furosemide is a loop diuretic medication used to treat fluid build-up due to heart failure, liver scarring, or kidney disease. Studies have shown that the early use of Furosemide was associated with lower mortality for heart Failure Patients.

Dexur’s analysis of Real-World Evidence based on Medicare Claims data showed that the use of Furosemide within 7 days of hospitalization was associated with lower hospital readmission rates for Heart Failure Patients at Florida Hospital in Orlando, Florida. Reduction in readmission rates helps hospitals improve their outcomes for various cost and quality programs. Dexur is an approved entity to perform Medicare claims data analysis, which it uses to perform quality outcomes analysis. Dexur has published several papers with Harvard Medical School on quality outcomes related topics. Dexur’s analysis of Drugs and their impact on quality outcomes, such as readmissions and mortality, are used by Hospitals, IDNs, and ACOs to implement best practices and manage Real World Evidence based risk factors.

By: Sara Riascos  Mar. 02, 2022

Heart Failure is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Furosemide is a loop diuretic medication used to treat fluid build-up due to heart failure, liver scarring, or kidney disease. Studies have shown that the early use of Furosemide was associated with lower mortality for heart Failure Patients.

Dexur’s analysis of Real-World Evidence based on Medicare Claims data showed that the use of Furosemide within 7 days of hospitalization was associated with lower hospital readmission rates for Heart Failure Patients at Memorial Hermann Southwest Hospital in Houston, Texas. Reduction in readmission rates helps hospitals improve their outcomes for various cost and quality programs. Dexur is an approved entity to perform Medicare claims data analysis, which it uses to perform quality outcomes analysis. Dexur has published several papers with Harvard Medical School on quality outcomes related topics. Dexur’s analysis of Drugs and their impact on quality outcomes, such as readmissions and mortality, are used by Hospitals, IDNs, and ACOs to implement best practices and manage Real World Evidence based risk factors.

By: Sara Riascos  Feb. 24, 2022

Heart Failure is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Furosemide is a loop diuretic medication used to treat fluid build-up due to heart failure, liver scarring, or kidney disease. Studies have shown that the early use of Furosemide was associated with lower mortality for heart Failure Patients.

Dexur’s analysis of Real-World Evidence based on Medicare Claims data showed that the use of Furosemide within 7 days of hospitalization was associated with lower hospital readmission rates for Heart Failure Patients at Cedars Sinai Medical Center in Los Angeles, California. Reduction in readmission rates helps hospitals improve their outcomes for various cost and quality programs. Dexur is an approved entity to perform Medicare claims data analysis, which it uses to perform quality outcomes analysis. Dexur has published several papers with Harvard Medical School on quality outcomes related topics. Dexur’s analysis of Drugs and their impact on quality outcomes, such as readmissions and mortality, are used by Hospitals, IDNs, and ACOs to implement best practices and manage Real World Evidence based risk factors.

By: Sara Riascos  Feb. 23, 2022

Heart Failure is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Furosemide is a loop diuretic medication used to treat fluid build-up due to heart failure, liver scarring, or kidney disease. Studies have shown that the early use of Furosemide was associated with lower mortality for heart Failure Patients.

Dexur’s analysis of Real-World Evidence based on Medicare Claims data showed that the use of Furosemide within 7 days of hospitalization was associated with lower hospital readmission rates for Heart Failure Patients at Methodist University Hospital in Memphis, Tennesee. Reduction in readmission rates helps hospitals improve their outcomes for various cost and quality programs. Dexur is an approved entity to perform Medicare claims data analysis, which it uses to perform quality outcomes analysis. Dexur has published several papers with Harvard Medical School on quality outcomes related topics. Dexur’s analysis of Drugs and their impact on quality outcomes, such as readmissions and mortality, are used by Hospitals, IDNs, and ACOs to implement best practices and manage Real World Evidence based risk factors.